Loading candles…
Kronox Lab Sciences Ltd, incorporated in 2008 and headquartered near Vadodara, Gujarat, is an Indian manufacturer of high-purity specialty fine chemicals. The company produces a range of inorganic chemicals including phosphates, metallic chemicals, sulfates, acetates, chlorides, citrates, and EDTA derivatives. These products serve multiple industries such as pharmaceuticals, nutraceuticals, biotech, agrochemicals, and scientific research. Kronox Lab Sciences Ltd complies with international standards including IP, BP, EP, JP, USP, and FCC. The company emphasizes high-quality standards and offers custom manufacturing solutions to its clients within India.
This page is a live market overview for KRONOX LAB SCIENCES LTD (KRONOX) on the NSE. As a listed security, KRONOX LAB SCIENCES LTD is tracked in the Chemicals segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for KRONOX before placing trades on tick2trade.
As of the latest feed, KRONOX last traded at ₹196.75 on NSE, up ₹0 (0.00%) from the previous close of ₹196.75. Today's session range is ₹0 – ₹0, against a 52-week band of ₹96 – ₹223.42. Traded volume today stands at 1.75L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for KRONOX in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether KRONOX is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for KRONOX LAB SCIENCES LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in KRONOX. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated KRONOX option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 12 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 21 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 14 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 11 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 11 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 22 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.